1. Home
  2. TENB vs TMDX Comparison

TENB vs TMDX Comparison

Compare TENB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenable Holdings Inc.

TENB

Tenable Holdings Inc.

HOLD

Current Price

$41.92

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$72.00

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENB
TMDX
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
TENB
TMDX
Price
$41.92
$72.00
Analyst Decision
Hold
Buy
Analyst Count
23
13
Target Price
$35.50
★ $98.73
AVG Volume (30 Days)
★ 3.1M
713.8K
Earning Date
10-28-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
3.23
★ 382.18
EPS
0.05
★ 0.61
Revenue
★ $999,405,000.00
$605,494,000.00
Revenue This Year
$7.94
$22.57
Revenue Next Year
$7.12
$17.85
P/E Ratio
$811.60
★ $119.75
Revenue Growth
11.04
★ 37.13
52 Week Low
$15.73
$60.11
52 Week High
$43.67
$156.00

Technical Indicators

Market Signals
Indicator
TENB
TMDX
Relative Strength Index (RSI) 61.30 36.32
Support Level $31.48 $66.64
Resistance Level $43.18 $79.60
Average True Range (ATR) 2.15 3.93
MACD 0.13 -0.62
Stochastic Oscillator 83.55 26.43

Price Performance

Historical Comparison
TENB
TMDX

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: